About Directive Strategy Group
Helping healthcare innovators navigate
reimbursement with confidence.
Supported
Trained
Founded in 2017 in San Diego, Directive Strategy Group helps pharmaceutical, medical device, and diagnostic companies navigate the complexities of reimbursement, coding, coverage, and market access strategy.
We partner with emerging and established healthcare innovators to develop reimbursement pathways that support commercialization, provider adoption, and long-term market success.
We work closely with leadership teams to align reimbursement strategy with clinical, regulatory, and commercial objectives—helping innovative technologies move from development to real-world adoption.
Successful innovation requires more than regulatory approval.
It requires a clear pathway to provider utilization, payer acceptance, and patient access.
Founder & CEO
Alyssa Foster, MA, COC
Directive Strategy Group is led by Alyssa Foster, a reimbursement and market access professional with extensive experience developing and implementing strategic pathways for novel pharmaceutical and medical device companies.
Alyssa has a passion for training and education and is known for taking complex reimbursement concepts and breaking them down into digestible pieces.
Alyssa is a certified coder and has a proven track record in securing new codes as well as new technology payments for her clients (e.g. J-codes, C-codes, G-codes, CPT, ICD-10, NTAP, NT-APC and pass-through payments). She has authored many coding guidance articles for AAPC Magazine and developed a course for the University of Arizona MBA program with a focus on professional development in the biotech industry.
Ready to Discuss Your
Reimbursement Strategy?
Every engagement begins with a conversation about your goals, reimbursement challenges, and commercialization strategy.
Schedule a Call